The Role of Venoactive Drugs in Venous Disorders [CME] (UIP2013-53)

This course will provide an overview of the impact and efficacy of venoactive drugs in venous disorders, and patients with venous edema. Discussions will include evidence of efficacy of micronized purified flavonoid fraction, edema and venoactive efficacy, and pharmacologic treatment in venous ulcer patients.

This course will include:

Chair: Albert–Adrien Ramelet, MD
 
Overview Venoactive Agents
Albert–Adrien Ramelet, MD
 
What is the Evidence for Venoactive Drug Efficacy?
Andrew Nicolaides, MD
 
Impact of Venoactive Drugs on Venous Edema
Francois–Andre Allaert, MD, PhD
 
What is the Evidence for the Efficacy of Micronized Purified Flavonoid Fraction?
Philip Coleridge–Smith, MD, FRCS
 
Pharmacologic Treatment of Venous Ulcer Patients
Armando Schapira, MD
 
New Biometric Tools for Evaluation of Edema and Venoactive Efficacy
Arkadiusz Jawien, MD
 
Guidelines for Efficacy Studies of Venoactive Agents
Michel Perrin, MD, FACPh
 
Discussion
All Speakers

 

Steps to Successfully Complete This Activity

To participate in this educational activity please follow the steps listed below.

If you are new to the ACP Online Education Center we require that you register prior to viewing any activity. Click the Register link located in the top right corner of this screen to do so. If you are already a registered user log in and click the TAKE COURSE button that will appear in the Course Summary box.

  1. To begin the activity click the START COURSE button.
  2. Progress through course content by using the NEXT button.
  3. Complete all required items in the course.
  4. Participants must score 80% or greater on the Post-Test to advance and receive credit. They are given three attempts to meet this threshold.
  5. Track your progress using the Course Progress menu.
  6. On the final page of the activity a link will be provided to download your certificate.

Target Audience

The content of this activity is designed to meet the needs of the following target audience:  phlebologists, general surgeons, vascular surgeons, interventional radiologists, interventional cardiologists, vascular medicine practitioners, dermatologists, dermatologic surgeons, family practice and internal medicine practitioners, plastic surgeons, obstetricians and gynecologists, cardiologists, and any other healthcare professional currently or planning on treating patients with venous disease.

Learning Objectives

As a result of this activity, the participant should be able to:

  1. Define the different classes of venoactive drugs.
  2. Define the mode of action and effectiveness of venoactive drugs in venous disorders.
  3. Choose correct and effective indications of venoactive drugs.
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
Course opens: 
10/10/2013
Course expires: 
03/25/2018
Cost:
$62.50
Parent activity set: 
XVII UIP World Meeting Online Sessions
Rating: 
0
NAMEROLECOMMERCIAL INTERESTTYPE OF RELATIONSHIP
Francois–Andre Allaert, MD, PhDSpeakerNONE 
Philip Coleridge–Smith, MD, FRCSSpeakerNONE 
Emily Cummings, MDContent ReviewerNONE 
Heather Durband, BSStaffNONE 
Antonio Gasparis, MDScientific Committee/PlannerCovidien; Cook; Vascular Insights; GoreConsultant/Speaker
Jean-Jérôme Guex, MD, FACPhScientific Committee/PlannerServier International; Thuasne; Vascular InsightsSpeaker/Consultant; Scientific Committee Member
Arkadiusz Jawien, MDSpeakerConvatec and SchulkeSpeaker
Mark Meissner, MDScientific Committee/PlannerHas nothing to discloseN/A
Nick Morrison, MD, FACS, FACPh, RPhSScientific Committee/PlannerMedi; Merz; BTG; VenXSpeaker; Consultant; Principal Investigator; Scientific Advisory Board
Andrew Nicolaides, MS, FRCS, PhD (Hon)SpeakerServier InternationalSpeaker
Michel Perrin, MD, FACPhSpeakerServier InternationalConsultant
Albert-Adrien Ramelet, MDSpeakerServier International; Boehringer IngelheimSpeaker
Melvin Rosenblatt, MD, FACPhScientific Committee/Planner/Content ReviewerHas nothing to discloseN/A
Armando Schapira, MDSpeakerNONE 
Sherry Scovell, MDContent ReviewerBolton Medical PPDData Safety and Monitoring Committee Member
Thomas Wakefield, MDScientific Committee/PlannerHas nothing to discloseN/A
Steven Zimmet, MD, RVT, FACPhScientific Committee/PlannerMerz AestheticsSpeaker

 

Disclaimer

The views and opinions expressed in this activity are those of the faculty and do not necessarily represent the views of the ACP. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting professional use of any of the information provided herein. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of ACP Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

Discussion of Off-Label Use

Although no longer required by the Accreditation Council for Continuing Medical Education (ACCME), ACP CME requests all faculty to inform learners of any products they will discuss that are off-label or investigational.

Reproduction Prohibited

Reproduction of this material is not permitted without written permission from the copyright owner.

Review & Recertification

This course was reviewed and recertified for AMA PRA Category 1 CreditTM on March 25, 2015.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance

Accreditation Period

Course opens: 
10/10/2013
Course expires: 
03/25/2018

Price

Cost:
$62.50
Please login or register to take this course.